Weekly analyst rating updates for Fresenius Medical Care AG & Co. KGaA (FME)

0

A number of research firms have changed their ratings and price targets to Fresenius Medical Care AG & Co. KGaA (ETR: EMF):

  • 05/25/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €51.00 ($54.26) from analysts at JPMorgan Chase & Co..
  • 05/24/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €82.20 ($87.45) from analysts at Berenberg Bank.
  • 5/11/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €75.00 ($79.79) from analysts at UBS Group AG.
  • 5/10/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €62.00 ($65.96) from analysts at Warburg Research.
  • 5/5/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €58.00 ($61.70) from analysts at Deutsche Bank Rese….
  • 05/05/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €61.00 ($64.89) from analysts at Credit Suisse Group AG.
  • 5/5/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €83.40 ($88.72) from analysts at Berenberg Bank.
  • 5/4/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €48.70 ($51.81) from analysts at JPMorgan Chase & Co..
  • 04/29/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €83.40 ($88.72) from analysts at Berenberg Bank.
  • 04/27/2022 – Fresenius Medical Care AG & Co. KGaA has been given a new price target of €48.70 ($51.81) by analysts at JPMorgan Chase & Co..
  • 26/04/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €68.00 ($72.34) from analysts at Barclays PLC.
  • 04/26/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €75.00 ($79.79) from analysts at UBS Group AG.

Shares of FME Share was down €0.10 ($0.11) during Monday trading hours, hitting €56.58 ($60.19). 338,504 shares of the company were traded, against an average volume of 704,197. The stock has a market capitalization of $16.58 billion and a P/E ratio of 18.89. Fresenius Medical Care AG & Co. KGaA has a 52-week minimum of €50.98 ($54.23) and a 52-week maximum of €71.14 ($75.68). The company has a quick ratio of 0.79, a current ratio of 1.26 and a debt ratio of 91.78. The company has a 50-day moving average of €59.65.

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Further reading



Get news and reviews for Fresenius Medical Care AG & Co KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co KGaA and related companies with MarketBeat.com’s free daily email newsletter.

Share.

Comments are closed.